Return to homepagePandemic Pact

to evaluate the effectiveness of a COVID-19 vaccine in Health Care Workers in South Africa

Grant number: INV-030342

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2021

  • Known Financial Commitments (USD)

    $2,500,000

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    South Africa

  • Lead Research Institution

    South African Medical Research Council

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health Personnel

Abstract

N/A

Publicationslinked via Europe PMC

Last Updated:42 minutes ago

View all publications at Europe PMC

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

High Asymptomatic Carriage With the Omicron Variant in South Africa.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.